SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Calypte Biomedical Corporation (CALY)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Lacelle who wrote (326)2/8/1999 3:41:00 PM
From: Cindy Powell  Read Replies (1) of 381
 
Dear John,

The tidal wave "could" happen, and I am prepared for it if'n it does, and also if'n it doesn't. CALY is best gauged as speculative and alot of volatility and drifting is to be expected with these speculative biotechs. IMGN was selling in the twenties years back, and "drifted" down to a dollar, but has since been rebounding since announcing partnering with Smithkline. IMGN has been a triple so far for aggressive investors that enchanted themselves with all the "if's."
IMGN may be worth a look to those who like the smaller biotechs. I love the smaller biotechs. If you can watch them consistently there is alot of opportunity for profits, but they need to be babysat because cash burn and other obstacles can send these guys smoking into the dust, unless they have technology that is competitive, novel and compelling. I think IMGN and CALY have all the above. I also think that in the coursing of their research and development, it is not unrealistic to hope for them to stumble upon something that may spell out C-U-R-E or t-r-e-a-t-m-e-n-t for AIDS. They are researching within all the sensitive parameters that could be conducive to new discoveries. I still love <3 CALY.

Best regards to all,
Cindy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext